This article first appeared on GuruFocus . Eli Lilly ( NYSE:LLY ) shares climbed nearly 2% on Monday after the drugmaker announced a major artificial i...
Visgo Therapeutics Competitors or Alternatives
Visgo Therapeutics's top competitors include Abazyme, Xalud and Anchor Therapeutics.
Visgo Therapeutics VS Abazyme
Abazyme is Visgo Therapeutics's biggest rival. Abazyme was founded in Needham Heights, Massachusetts} in 2005. Like Visgo Therapeutics, Abazyme also competes in the Pharmaceuticals & Biotechnology sector. Compared to Visgo Therapeutics, Abazyme generates $42.9M more revenue.
Visgo Therapeutics VS Xalud
Xalud is Visgo Therapeutics's #2 rival. Xalud's headquarters is in New York, New York, and was founded in 2009. Like Visgo Therapeutics, Xalud also competes in the Biotechnology space. Xalud generates 60% of Visgo Therapeutics's revenue.
Visgo Therapeutics VS Anchor Therapeutics
Anchor Therapeutics is Visgo Therapeutics's #3 competitor. Anchor Therapeutics was founded in 01/2006 in Cambridge, Massachusetts. Like Visgo Therapeutics, Anchor Therapeutics also works within the Biotechnology sector. Anchor Therapeutics generates $2.3M less revenue than Visgo Therapeutics.
Looking for similar companies to Visgo Therapeutics?
Similar Companies
Biotechnology companies in Burlington
See 34 companies
Biotechnology companies in Greater BostonSee 1,264 companies
Pharmaceuticals & Biotechnology companies in BurlingtonSee 60 companies
Biotechnology companies in MassachusettsSee 1,339 companies
Pharmaceuticals & Biotechnology companies in Greater BostonSee 1,625 companies
Pharmaceuticals & Biotechnology companies in MassachusettsSee 1,717 companies
Biotechnology companies with revenue in $5.0-25M rangeSee 3,634 companies
Biotechnology companies with employees in 25-100 rangeSee 5,178 companies
Companies in Burlington with revenue in $5.0-25M rangeSee 5,217 companies
Trending News for Visgo Therapeutics and Visgo Therapeutics's Competitors
On Saturday, Pfizer Inc. (NYSE:PFE) shared data from Cohort 3 of the BREAKWATER trial. The Phase 3 BREAKWATER trial evaluated Braftovi (encorafenib) wi...
The pharmaceutical manufacturer joins several others in lowering prices on some drugs and planning to offer them through TrumpRx. It is also building t...
Novartis to Build 4th US Radioligand Therapy Facility in Florida, Expanding $23B Investment...
AbbVie has announced a deal with the White House to lower the prices of certain medicines on Medicaid. At the same time, the Chicago-based company pled...
Ro's and Amgen's research will focus on barriers to care and improving access to treatment NEW YORK, Jan. 13, 2026 /PRNewswire/ -- Ro, the leading dire...
SAN FRANCISCO-Bristol Myers Squibb is already aiming to launch more than 10 new medicines by 2030. But to hear CEO Chris Boerner, Ph.D., tell it, "busi...
A Walmart worker in a holiday costume gathers shopping carts in the parking area of a Walmart Supercenter store in Monroe, New York, U.S., December 9, ...
Frequently Asked Questions about Visgo Therapeutics
Who are Visgo Therapeutics's top competitors?
Visgo Therapeutics's top 3 competitors are Abazyme, Xalud, Anchor Therapeutics.Who is similar to Visgo Therapeutics?
Abazyme is the most similar to Visgo Therapeutics. Xalud and Anchor Therapeutics are also similar to Visgo Therapeutics.
Are Visgo Therapeutics and Abazyme competitors?
Yes, Abazyme is one of Visgo Therapeutics’s top competitors.